High Streptococcus pneumoniae colonization prevalence among HIV-infected Kenyan parents in the year before pneumococcal conjugate vaccine introduction.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 26774803)

Published in BMC Infect Dis on January 16, 2016

Authors

Laura M Conklin1,2, Godfrey Bigogo3,4, Geofrey Jagero5, Lee Hampton6, Muthoni Junghae7, Maria da Gloria Carvalho8, Fabiana Pimenta9, Bernard Beall10, Thomas Taylor11, Brian Plikaytis12, Kayla F Laserson13, John Vulule14, Chris Van Beneden15, Cynthia G Whitney16, Robert F Breiman17, Daniel R Feikin18

Author Affiliations

1: Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. dvj3@cdc.gov.
2: Respiratory Diseases Branch, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS C-25, Atlanta, GA, 30333, USA. dvj3@cdc.gov.
3: Kenya Medical Research Institute/Centers for Disease Control and Prevention, Kisumu, Kenya. gbigogo@kemricdc.org.
4: KEMRI/CDC Research Collaboration, P. O. Box 1578, Kisumu, 40100, Kenya. gbigogo@kemricdc.org.
5: Kenya Medical Research Institute/Centers for Disease Control and Prevention, Kisumu, Kenya. gjagero@icipe.org.
6: Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. euf0@cdc.gov.
7: Kenya Medical Research Institute/Centers for Disease Control and Prevention, Kisumu, Kenya. ivq4@cdc.gov.
8: Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. msc8@cdc.gov.
9: Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. gzy7@cdc.gov.
10: Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. beb0@cdc.gov.
11: Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. tkt1@cdc.gov.
12: Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. bdplikaytis@gmail.com.
13: Kenya Medical Research Institute/Centers for Disease Control and Prevention, Kisumu, Kenya. kel4@cdc.gov.
14: Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya. jvulule@kemricdc.org.
15: Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. cav7@cdc.gov.
16: Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. cgw3@cdc.gov.
17: Kenya Medical Research Institute/Centers for Disease Control and Prevention, Kisumu, Kenya. rfbreiman@emory.edu.
18: Kenya Medical Research Institute/Centers for Disease Control and Prevention, Kisumu, Kenya. drf0@cdc.gov.

Articles cited by this

Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med (2003) 15.48

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis (2010) 8.37

Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis (2008) 4.91

Effect of reduction in household air pollution on childhood pneumonia in Guatemala (RESPIRE): a randomised controlled trial. Lancet (2011) 4.79

Accuracy of phenotypic and genotypic testing for identification of Streptococcus pneumoniae and description of Streptococcus pseudopneumoniae sp. nov. J Clin Microbiol (2004) 3.96

Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis (2005) 3.76

Health and demographic surveillance in rural western Kenya: a platform for evaluating interventions to reduce morbidity and mortality from infectious diseases. Am J Trop Med Hyg (2005) 3.15

Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med (2000) 2.85

Report from a WHO working group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J (2003) 2.83

Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes. J Clin Microbiol (2010) 2.79

The burden of common infectious disease syndromes at the clinic and household level from population-based surveillance in rural and urban Kenya. PLoS One (2011) 2.63

Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. J Infect Dis (2006) 2.30

The epidemiology of pneumococcal infection in children in the developing world. Philos Trans R Soc Lond B Biol Sci (1999) 2.17

Underestimation of HIV prevalence in surveys when some people already know their status, and ways to reduce the bias. AIDS (2013) 2.06

Home-based HIV testing and counseling in rural and urban Kenyan communities. J Acquir Immune Defic Syndr (2013) 1.98

Shifting genetic structure of invasive serotype 19A pneumococci in the United States. J Infect Dis (2011) 1.75

Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics (2010) 1.72

Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med (2006) 1.67

Etiology and Incidence of viral and bacterial acute respiratory illness among older children and adults in rural western Kenya, 2007-2010. PLoS One (2012) 1.64

Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect Dis (2004) 1.57

Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of pneumococcal disease. BMC Infect Dis (2010) 1.53

Transmission of Streptococcus pneumoniae in rural Gambian villages: a longitudinal study. Clin Infect Dis (2010) 1.52

Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities. J Infect Dis (2011) 1.51

The preventable burden of pneumococcal disease in the developing world. Vaccine (2006) 1.48

Pre-vaccination nasopharyngeal pneumococcal carriage in a Nigerian population: epidemiology and population biology. PLoS One (2012) 1.37

The prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in Kilifi District, Kenya. PLoS One (2012) 1.34

Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization. AIDS (2010) 1.32

HIV and pneumococcal disease. Curr Opin Infect Dis (2007) 1.30

High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. Pediatrics (2001) 1.26

Streptococcus pneumoniae blood culture isolates from patients with and without human immunodeficiency virus infection: alterations in penicillin susceptibilities and in serogroups or serotypes. Clin Infect Dis (1997) 1.23

Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults? Am J Trop Med Hyg (2008) 1.23

Impact of human immunodeficiency virus infection on Streptococcus pneumoniae colonization and seroepidemiology among Zambian women. J Infect Dis (2008) 1.13

The dynamics of nasopharyngeal streptococcus pneumoniae carriage among rural Gambian mother-infant pairs. BMC Infect Dis (2010) 1.11

Association of secondhand smoke exposure with pediatric invasive bacterial disease and bacterial carriage: a systematic review and meta-analysis. PLoS Med (2010) 1.11

Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine. J Infect Dis (2005) 1.10

High rate of pneumococcal bacteremia in a prospective cohort of older children and adults in an area of high HIV prevalence in rural western Kenya. BMC Infect Dis (2010) 1.09

Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adults. Clin Diagn Lab Immunol (2004) 0.98

Gender as a risk factor for both antibiotic resistance and infection with pediatric serogroups/serotypes, in HIV-infected and -uninfected adults with pneumococcal bacteremia. J Infect Dis (2004) 0.94

Impact of cotrimoxazole on non-susceptibility to antibiotics in Streptococcus pneumoniae carriage isolates among HIV-infected mineworkers in South Africa. J Infect (2008) 0.93

Pneumococcal carriage among indigenous Warao children in Venezuela: serotypes, susceptibility patterns, and molecular epidemiology. Clin Infect Dis (2007) 0.93

Oropharyngeal colonization by Streptococcus pneumoniae among HIV-infected adults in Uganda: assessing prevalence and antimicrobial susceptibility. Int J Infect Dis (2006) 0.90

Prevalence, serotypes, and risk factors for pneumococcal carriage among HIV-infected adults. Diagn Microbiol Infect Dis (2007) 0.89

Herd immunity after pneumococcal conjugate vaccination. Lancet (2007) 0.87

Acquisition of Streptococcus pneumoniae in pneumococcal conjugate vaccine-naïve South African children and their mothers. Pediatr Infect Dis J (2013) 0.85

Trends in serotype prevalence in invasive pneumococcal disease before and after infant pneumococcal vaccination in Belgium, 2002-2010. Vaccine (2012) 0.84

Nasopharyngeal carriage of Streptococcus pneumoniae: prevalence and risk factors in HIV-positive children in Tanzania. Int J Infect Dis (2012) 0.83

Cross-sectional study of nasopharyngeal carriage of Streptococcus pneumoniae in human immunodeficiency virus-infected adults in the conjugate vaccine era. J Clin Microbiol (2008) 0.82

Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States. J Infect Dis (2003) 0.78